National Cancer Institute (NCI): Lymphoma, Large B-Cell, Diffuse trials

The registry lists 104 Lymphoma, Large B-Cell, Diffuse studies with National Cancer Institute (NCI) as lead sponsor. 8 are open to participants now and 33 have results posted.

Early Phase 1 1Phase 1 64Phase 2 49Phase 3 3No phase 1(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00003210Phase 2
• Bryostatin and Vincristine in B-Cell MalignanciesCompletedNCT00003166Phase 1
• Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00002649Phase 3
• Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell LymphomasCompletedNCT00001237Phase 2